Long-term outcomes of enzyme replacement therapy from a large cohort of Korean patients with mucopolysaccharidosis IVA (Morquio A syndrome)

Mucopolysaccharidosis (MPS) IVA (Morquio A syndrome) is an autosomal recessive lysosomal storage disorder caused by a mutation affecting the enzyme N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4, GALNS). Enzyme replacement therapy (ERT) has been shown to improve physical performance, quality of life,...

Full description

Bibliographic Details

Published in:	Molecular Genetics and Metabolism Reports
Main Authors:	Juyoung Sung, Insung Kim, Minji Im, Yoon Ji Ahn, Sang-Mi Kim, Ja-Hyun Jang, Hyung-Doo Park, Tae Yeon Jeon, Kyung Rae Ko, Se-Jun Park, Jun Hwa Lee, Eun Young Kim, Chong Kun Cheon, Eungu Kang, Jung-eun Moon, Young Bae Sohn, Hsiang-Yu Lin, Chih-Kuang Chuang, Shuan-Pei Lin, Sung Yoon Cho
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Subjects:	Dysostosis multiplex Elosulfase alfa Morquio A syndrome Enzyme replacement therapy MPS IVA Mucopolysaccharidosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214426925000047